Microvascular changes at different stages of chronic kidney disease

• DOI: 10.1111/jch.14138
• Publication Date: 2020-12-19T11:56:34Z
• Authors: Dennis Kannenkeril; Shaun Frost; Janis M. Nolde; Márcio Galindo Ki...; Revathy Carnagarin; Leslie Marisol Lu...; Justine Chan; Anu Joyson; Vance B. Matthews; Lakshini Y. Herat; Omar Azzam; Maryam Mehdizadeh; Janardhan Vignarajan; Yogesan Kanagasingam; Markus P. Schlaich
• Keywords: glomerular filtration rate; retinal vessel caliber hypertension sympathetic nervous system; Retinal Vessels; 3. Good health; Arterioles; 03 medical and health sciences; 0302 clinical medicine; RC666-701; microvascular change; Hypertension; Diseases of the circulatory (Cardiovascular) system; Microvascular Changes; Humans; Renal Insufficiency, Chronic; chronic kidney disease; Glomerular Filtration Rate

AbstractPatients with progressing chronic kidney disease (CKD) are more likely to experience cardio‐ and cerebrovascular events than progressing to end‐stage renal disease. The authors explored whether retinal microvascular calibers differed with the degree of renal impairment and between the standard and extended optic disk and may serve as a simple additional tool for risk stratification in this highly vulnerable patient cohort. The authors analyzed central retinal arteriolar and venular equivalent calibers (CRAE, CRVE) at different retinal zones (zone B&C) using digital retinal imaging in hypertensive patients with stage 2 (n = 66) or stage 3 CKD (n = 30). Results were adjusted for age, sex, HbA1c, and 24‐hour diastolic blood pressure. Mean eGFR was 77.7 ± 8.9 and 48.8 ± 7.9 ml/min/1.73 m2 for stage 2 and 3 CKD, respectively. CRAE and CRVE in zones B and C were significantly lower in patients with stage 3 CKD compared to patients with stage 2 CKD (CRAE‐B:141.1 ± 21.4 vs. 130.5 ± 18.9 µm, p = .030; CRAE‐C:137.4 ± 19.4 vs 129.2 ± 18.2 µm, p = .049; CRVE‐B:220.8 ± 33.0 vs. 206.0 ± 28.4 µm, p = .004; and CRVE‐C:215.9 ± 33.0 vs. 201.2 ± 25.1µm, p = .003). In patients with stage 2 CKD, CRAE‐B was higher than CRAE‐C (141.1 ± 21.4 vs. 137.4 ± 19.4µm, p < .001). In contrast, such a difference was not found in patients with stage 3 CKD. CRAE of both retinal zones correlated with eGFR for the entire cohort. In patients with stage 3 CKD, retinal narrowing is more pronounced compared to patients with stage 2 CKD. Whether the novel observation of difference in arteriolar caliber between zones B and C in stage 2 CKD could serve as an early marker of CKD progression warrants further investigation.